More importantly, we observed that WDR62 expression in triple-negative breast cancer (TNBC) was higher than that in other subtypes, suggesting that a distinct mechanism may exist for WDR62 in BRCA subtypes. This evidence concerns the gene WDR62 and triple-negative breast carcinoma.